WACKER at a Glance

As an innovative chemical company, WACKER makes a vital contribution to improving the quality of life around the world. We want to continue developing and supplying solutions that meet our own expectations of adding value for our customers and shareholders, and of growing sustainably.

 (XLS:) Download XLS

 

  

 

  

 

€ million

  

2018

  

2017

  

Change in %

1

EBITDA is EBIT before depreciation and amortization.

2

Margins are calculated based on sales.

3

EBIT is the result from continuing operations for the period before interest result and other financial result, and income taxes.

4

Sum of cash and cash equivalents, noncurrent and current securities, and noncurrent and current financial liabilities.

5

Excluding acquisitions.

6

Sum of cash flow from operating activities (excluding changes in advance payments received) and cash flow from long-term investing activities (before securities), including additions due to finance leases.

 

  

 

  

 

  

 

Results / Return

  

 

  

 

  

 

Sales

  

4,978.8

  

4,924.2

  

1.1

EBITDA1

  

930.0

  

1,014.1

  

-8.3

EBITDA margin2 (%)

  

18.7

  

20.6

  

n.a.

EBIT3

  

389.6

  

423.7

  

-8.0

EBIT margin2 (%)

  

7.8

  

8.6

  

n.a.

 

  

 

  

 

  

 

Financial result

  

-65.2

  

-96.3

  

-32.3

Income from continuing operations before income taxes

  

324.4

  

327.4

  

-0.9

Income from continuing operations

  

260.1

  

250.1

  

4.0

Income from discontinued operations

  

–

  

634.7

  

-100.0

Net income for the year

  

260.1

  

884.8

  

-70.6

 

  

 

  

 

  

 

Earnings per share from continuing operations (basic / diluted) (€)

  

4.95

  

4.85

  

2.2

Earnings per share (basic / diluted) (€)

  

4.95

  

17.45

  

-71.6

ROCE (%)

  

5.9

  

7.5

  

n.a.

 

  

 

  

 

  

 

Financial Position / Cash Flows

  

 

  

 

  

 

Total assets

  

7,118.7

  

6,835.7

  

4.1

Equity

  

3,145.5

  

3,169.3

  

-0.8

Equity ratio (%)

  

44.2

  

46.4

  

n.a.

Financial liabilities

  

997.2

  

1,001.6

  

-0.4

Net financial debt4

  

609.7

  

454.4

  

34.2

Capital expenditures (continuing operations)5

  

460.9

  

326.8

  

41.0

Depreciation (continuing operations)

  

-540.4

  

-590.4

  

-8.5

Net cash flow (continuing operations)6

  

124.7

  

358.1

  

-65.2

 

  

 

  

 

  

 

Research and Development

  

 

  

 

  

 

Research and development expenses (continuing operations)

  

164.6

  

153.1

  

7.5

 

  

 

  

 

  

 

Employees

  

 

  

 

  

 

Personnel expenses (continuing operations)

  

1,231.5

  

1,198.0

  

2.8

Employees (December 31, number)

  

14,542

  

13,811

  

5.3

todo Vorjahresvergleich